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Introduction
Tuberculosis (TB) and Human Immunodeficiency 
Virus/Acquired Immunodeficiency Syndrome (HIV/
AIDS) are the major public health issue in many parts 
of the world particularly in resource-limited countries, 
TB remains an important cause of ill health, and the 
major cause of mortality from a single infectious agent, 
rated above (HIV/AIDS) in the top 10 diseases that 
cause high mortality rates (WHO 2019a).
HIV is one of the most significant threat to the global 
control of TB (Mukadi et al. 2001). By severely com-
promising the immune system, HIV facilitates TB dis-
semination and raises the mortality of co-infected indi-
viduals as opposed to TB patients who are HIV negative 
(Mukadi et al. 2001; Zumla et al. 2015). Both diseases 
are directly connected, and the number of co-infected 
patients continues to increase rapidly (Karim 2006).
HIV is a potential risk accountable for latent TB pro-
gressing to active TB (Davy-Mendez et al. 2019). People 
living with HIV are 19 (15–22) times more probable 
than people without HIV to develop active TB disease, 
which demonstrates the seriousness of this deadly com-
bination. Worldwide about 251,000 people have died of 
HIV-associated TB in 2018, and an estimated 862,000 
new cases of TB have been identified among HIV-
positive individuals, 72% among whom live in Africa. 
With 95% of global TB deaths and more than 70% of 
the global HIV burden, sub-Saharan Africa bears the 
greatest burden of both diseases (Gwitira et al. 2018). 
Sudan one of the resources limited countries with major 
issues in health, in 2018 the total incidence of TB in 
Sudan was 30,000 (21,000–41,000), with 71  (49–98) 
rates per 100,000. The HIV-positive TB incidence was 
estimated to be 970 (300–2,000), with 2.3  (0.72–4.8) 
rate per 100,000 (WHO 2019b), and Eastern Sudan 
remain as an endemic area of TB (Abdallah et al. 2012).
While the HIV epidemic continues to fuel the global 
TB epidemic, the significance of HIV surveillance in TB 
patients is widely recognized (Manjareeka and Nanda 
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Tuberculosis (TB) is a leading cause of death in patients infected with Human Immunodeficiency Virus (HIV), and HIV infection is the 
most potent risk factor for the development of active TB disease from a latent TB infection. This study aims to determine the seroprevalence 
of HIV among newly diagnosed TB patients in Kassala state eastern Sudan. This was a descriptive, hospital-based, cross-sectional study 
of 251 active and newly diagnosed TB patients, selected by simple random sampling. Blood samples and demographic data were collected 
from each patient. TB was diagnosed by direct ZN smear and molecular detection by Xpert MTB/RIF. The serum samples were tested for 
HIV using 4th generation enzyme-linked immunosorbent assay (ELISA). The prevalence of HIV was 13.9% (35/251), the infection rate 
among pulmonary TB was 17%, whereas that in extrapulmonary TB was 4.8%, the prevalence was (18.2%) in the males, and (7.2%) in the 
females. In conclusion: TB/HIV co-infection in the Eastern part of Sudan was high compared with the global prevalence, all TB patients 
should therefore be assessed for HIV risk factors and advised to undergo HIV testing.
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2013). The main components of both HIV and TB 
programmers’ are early diagnosis and treatment (Geta-
hun et al. 2011). The 2012 updates issued by the World 
Health Organization on the Guidelines for TB/HIV Col-
laborative Activities in 2004 recommend HIV testing 
not only for diagnosed TB patient, but among patients 
with suspected TB also (WHO 2012). The optimal time 
to begin antiretroviral therapy (ART) has been carefully 
evaluated in patients with both TB and HIV infection 
(Han et al. 2014). Immune reconstitution inflamma-
tory syndrome (IRIS), pharmacological interactions, 
and high pill burden have repeatedly claimed against 
concurrent therapy for both HIV and TB (Piscitelli 
and Gallicano 2001; Shelburne et al. 2002; Blanc et al. 
2007; Kaplan et al. 2009). On the other hand, a delay in 
launching ART is correlated with disease progression 
and increased mortality, notably in severely immuno-
suppressed patients (Kwara et al. 2004; Breen et al. 2005).
This study aimed to estimate the seroprevalence 
of HIV infection among active pulmonary and extra- 
pulmonary tuberculosis patients, and the level of 
knowledge in Kassala state, which is located in eastern 
Sudan near the Eritrean border, 600 kilometers from 
the Khartoum capital of Sudan with a great variety in 
culture, beliefs, language, and ethnicity.
Experimental
Materials and Methods
This was descriptive cross-sectional hospital-based 
study undertaken in Kassala State, Eastern of Sudan to 
investigate the prevalence of HIV among active pulmo-
nary and extrapulmonary TB patients. A total of 251 TB 
patients attending Kassala Teaching Hospital during the 
period of the study were recruited by simple random 
sampling after consent was obtained. Information, such 
as age, gender, socioeconomic background, education 
level, and residence area, was collected by a structured 
questionnaire. All patients were tested for TB according 
to the recommendations of the national TB program by 
using direct ZN stain and Xpert MTB/RIF (Cepheid, 
Sunnyvale, CA, USA).
TB diagnosis. AFB smear microscopy. Specimens 
were processed using the N-acetyl-L-cysteine-NaOH 
(NALC-NaOH) method for digestion and decontami-
nation. Specimens were concentrated by centrifugation 
at 3,200 × g for 20 min, and sediments were reconsti-
tuted with approximately 2 ml of 0.067 M sterile phos-
phate buffer (pH 6.8). Smear microscopy was per-
formed on processed sediments using Ziehl-Neelsen 
(ZN) staining. Smear-positive specimens were graded 
from 1+ to 4+ according to CDC guidelines (American 
Thoracic Society/CDC 2000)
Xpert MTB/RIF assay. The Xpert MTB/RIF assay 
was run on the GeneXpert Dx instrument system 
according to the manufacturer’s recommendations 
(Cepheid, Sunnyvale, CA, USA). Briefly, after diges-
tion, decontamination and concentration, 0.5 ml of 
re-suspended sediment was transferred to a conical 
screw-capped tube, 1.5 ml of Xpert MTB/RIF sample 
reagent was added by sterile pipette, and the tube was 
recapped and shaken vigorously 10–20 times. The sam-
ple was incubated for a total of 15 minutes at 20–30°C, 
with manual agitation 10–20  times at one point 
between 5 and 10 minutes into the incubation period. 
The reagent-treated sample was then transferred by 
sterile pipette into the sample chamber of the Xpert 
MTB/RIF cartridge and loaded into the GeneXpert Dx 
instrument system for sample processing. In the event 
of “no result”, “invalid” or “error” results, the test was 
repeated according to the manufacturer’s recommenda-
tions using a new Xpert MTB/RIF cartridge.
Blood samples were collected from each patient, 
then serum samples were separated (Tognon et al. 2020) 
and investigated for HIV antibodies by using fourth-
generation enzyme-linked immunosorbent assay 
(ELISA) according to the manufacturer’s instructions.
Data was analyzed by IBM SPSS Statistics for 
Windows, Version 20 (Armonk, NY: IBM Corp) and 
iNZight (The University of Auckland New Zealand). 
Chi-square test was used to test the p-value, and it 
was deemed significant if it was less than 0.05. Ethical 
approval for this study was received from the Health 
Research Ethics Committee of the Ministry of Health 
in Kassala state. The patients consent was acquired from 
each participant prior to the sample collection.
Results
A number of 251 TB patients have consented to 
take part in this study. Of those patients, 188 (74.9%) 
were newly diagnosed with pulmonary TB, and the 
remaining 63 (25.1%) were complaining of extrapul-
monary TB.
Gender, age, and residence. Out of 251 patients, 
154 (61.35%) were male and 97 (38.65%) were female. 
Their age was ranged from 4 years to 80 years, and the 
mean was 41.7 ± 17.9 years. On the basis of the residence 
of the studied population, 145 (57.77%) were residing in 
urban areas in the city, whereas 106 (42.23%) resided 
in rural areas around the city.
Social, behavioral, and HIV/TB knowledge data. 
In terms of social data (marital status, educational level, 
and occupation) and knowledge about TB and HIV, 
the study population was separated into two groups: 
children with less than 18 years old, and adults above 
18 years old. Their distribution was 21 (8.37%) and 
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230 (91.63%) in the children and adult groups, respec-
tively. These variables were analyzed separately.
As shown in Table I, the marital status of the adult 
group was divided into the following categories: mar-
ried (167; 72.1%), single (61; 26.52%), and widowed 
(2; 0.87%). Their smoking behavior was as follows: 
217 (94.35%) were nonsmokers, while 13 (5.65%) were 
smokers.
good knowledge, while the remaining 225 (97.83%) 
showed poor knowledge.
In terms of HIV knowledge, 24 (10.43%) out of 
230 adults showed good knowledge, while 206 (89.57%) 
showed poor knowledge.
The frequencies of the extracted children’s data were 
as follows. Their mean age was 13.38 ± 2.94 years, 14 of 
them were male (66.67%), and 7 were female (33.33%). 
Thirteen of them were uneducated (61.90%), while 
8 had an elementary education (38.10%). All of them 
had poor knowledge about TB, and only one had good 
knowledge about HIV (4.76%).
Overall, out of 251 patients tested for HIV, 35 
showed positive results with a prevalence of 13.9%, 
while 216 (86.1%) showed negative results (Table II).
Marital Status married 167 72.61%
 single 61 26.52%
 widow 2 0.87%
Educational level illiterate 159 69.13%
 elementary 59 25.65%
 secondary 11 4.78%
 university 1 0.43%
Occupation non 1 0.43%
 farmer 1 0.43%
 housewife 82 35.65%
 officer 2 0.87%
 worker 140 60.87%
 student 4 1.74%
Smoking smoker 13 5.65%
 non smoker 217 94.35%
Alcohol alcoholic 1 99.57%
 non alcoholic 229 0.43%
Knowledge about TB good 5 2.17%
 poor 225 97.83%
Knowledge about HIV good 24 10.43%
 poor 206 89.57%
Table I
Frequency of social behavior, and knowledge about TB/HIV,
of adults (n = 230).
Adults patients (Total 230)
Gender male 14  66.67%
 female 7  33.33%
Education elementary 8  38.10%
 uneducated 13  61.90%
Knowledge about TB good 0   0.0%
 poor 21 100%
Knowledge about HIV good 1   4.76%
 poor 20  95.24%
Table II
Frequency of gender, education, Knowledge about TB, knowledge 
about HIV, and occupation of children (n = 21).
Children patients (Total 21)
When the types of TB was compared with HIV 
infection, the infection rate among pulmonary TB was 
17%, whereas that in extrapulmonary TB was 4.8%; this 
was statistically significant (p = 0.03; Table III).
Pulmonary TB 32 (17%) 156 (83%) 188
Extra pulmonary  3 (04.8%)  60 (95.2%) 63 0.026
Total 35 (13.9%) 216 (86.1%) 251
Table III





The mean age of HIV-positive patients with TB was 
31.66 ± 12.80 years, while 43.35 ± 18.16 years in HIV-
negative patients.
Regarding gender, the infection of HIV among males 
was 18.2%, while that among females was 7.2%; the dif-
ference was statistically significant (p = 0.02; Table IV).
No statistical significance was detected when com-
paring the residence of patients with HIV infection fre-
quency (p = 0.9). The frequency was 14.5% in patients 
residing in the urban area, while that was 13.2% in 
patients residing in a rural area (Table IV).
The education level of 230 adults was as follows: 
illiterate (159; 69.13%), elementary education (59; 
25.65%), secondary education (11; 04.78%), and uni-
versity education (1; 0.43%).
Occupation of the adults’ population was spread into 
unemployment, farmer, housewife, officer, free worker, 
and students, with the following frequencies: 1 (0.43%), 
1 (0.43%), 82 (35.65%), 2 (0.87%), 140 (60.87%), and 
4 (1.74%), respectively.
Alcohol drinking was one of the behavioral data col-
lected, only one patient was alcoholic.
Knowledge about TB and HIV, transmission, and 
treatment were measured by asking different questions. 
Specifically, a patient who knew two-thirds or more 
was considered someone who had good knowledge, 
whereas a patient who knew one-third or less was con-
sidered someone with poor knowledge. Regarding TB 
knowledge, only 5 (2.17%) out of 230 adults showed 
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Regarding the patients’ knowledge about TB in 
comparison with HIV infection, out of all 251 patients, 
20% of patients with good knowledge were found to 
be HIV positive, while 13.8% of patients with poor 
knowledge were HIV positive. The p-value was 0.69, it 
was not statistically significant (Table IV). Considering 
patients’ knowledge about HIV and the frequency of 
infection, 24% of patients with good knowledge were 
positive for HIV, while 12.8% HIV-positive patients 
had poor knowledge, with no statistical significance 
between the two groups (p = 0.13; Table IV). Table V 
demonstrates the social and behavioral characteristics 
of adult patients (above 18 years old) with TB compared 
with HIV infection. First, regarding the education of 
HIV-positive patients, 14.5% were illiterate, 11.9% had 
an elementary education, 9.1% had secondary educa-
tion, and 0.0% were university studied patients; this was 
not statistically significant (p = 0.89).
Second, marital status and HIV results were com-
pared. The frequency of HIV-positive patients was 6.6% 
married, 32.8% single, and 0.0% widowed; the differ-
ence was not statistical significant (p = 1.6).
Third, the occupation of patients with TB was com-
pared with the HIV results. No positive HIV results 
were found among the unemployed and officers, and 
6.1% were found to be HIV positive in housewives. 
Approximately 17.1% of HIV-positive samples were free 
workers, only one farmer was HIV positive (100%), and 
25% of students were found to be HIV positive.
Fourth, smoking behavior in adult patients was 
compared with HIV results. The frequency of HIV-
positive results was 61.5% among smokers, and 10.6% 
Gender male 28 (18.2%) 126 (81.8%) 154 
0.02
 female  7 (7.2%)  90 (92.8%) 97
Residence urban 21 (14.5%) 124 (85.5%) 145 
0.92
 rural 14 (13.2%)  92 (86.8%) 106
Knowledge about TB good  1 (20%)   4 (80%) 5 
0.69
 poor 34 (13.8%) 212 (86.2%) 246
Knowledge about HIV good  6 (24%)  19 (76%) 25 
0.13
 poor 29 (12.8%) 197 (87.2%) 226
Total   4 (19.05%)  17 (80.95% 21
Table IV
Frequency of HIV in comparison to gender, education, Knowledge about TB,
knowledge about HIV, and occupation of children (n = 251).
Positive Negative Total p-value
Education illiterate 23 (14.5%) 136 (85.5%) 159
 elementary  7 (11.9%)  52 (88.1%) 59 
0.89
 secondary  1 (9.1%)  10 (90.9%) 11
 university  0 (0.0%)   1 (100%) 1
Marital status married 11 (6.6%) 156 (93.4%) 167
 single 20 (32.8%)  41 (67.2%) 61 0.6
 widow  0 (0.0%)   2 (100%) 2
Occupation unemployed  0 (0.0%)   1 (100%) 1
 housewife  5 (6.1%)  77 (93.9%) 82
 freeworker 24 (17.1%) 116 (82.9%) 140 
0.03
 officer  0 (0.0%)   2 (100%) 2
 farmer  1 (100%)   0 (0.0%) 1
 student  1 (25%)   3 (75%) 4
Smoking smoker  8 (61.5%)   5 (38.5%) 13 
0.7
 non smoker 23 (10.6%) 194 (89.4%) 217
Alcohol yes  0 (0.0%)   1 (100%) 1 
0.69
 no 31 (13.5%) 198 (86.5%) 229
Total  31 (13.5%) 199 (86.5%) 230
Table V
Frequency of HIV in comparison to gender, education, and occupation of adults (n = 230).
Positive Negative Total p-value
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among nonsmokers; the difference was not statistically 
significant (p = 1.7).
Lastly, regarding adult data, alcohol drinking was 
compared with HIV results. Approximately 13.5% non-
alcoholics were positive for HIV, while only one patient 
who drank alcohol was HIV negative.
Discussion
The prevalence of HIV in patients with TB is a res-
pon sive predictor of the spread of HIV to the general 
population in many regions. In order to respond to 
a  grow ing commitment to providing comprehensive 
HIV/AIDS treatment and support, including anti-retro-
viral therapy (ART), for HIV-positive patients with TB, 
information on HIV prevalence in patients with TB is 
important. Currently, while TB cases are increasingly 
being found in most countries, most cases of HIV are not.
The current study revealed that the prevalence of 
HIV in TB patients was 13.9%. These findings were 
lower than a similar study conducted in Kassala in 
2012, where the frequency was reported as 18.3% 
(Abdallah et al. 2012).
This frequency was also lower than those reported 
by studies carried out in Nigeria, Ghana, Ethiopia and 
Zambia (Yassin et al. 2004; Erhabor et al. 2010; Pennap 
et al. 2010; Chanda-Kapata et al. 2017; Osei et al. 
2017) but higher than those in studies in India, China, 
Pakistan, and Vietnam (Thanh et al. 2010; Wang et al. 
2010; Hasnain et al. 2012; Manjareeka and Nanda 
2013). The large variation in TB/HIV co-infection rates 
worldwide is partly due to the following reasons: under-
reporting, diagnostic procedures used, disparity in TB 
diagnosis, TB epidemiology in different countries, and 
methods used in the study.
The present study showed a high prevalence of 
HIV in males than in females, which was in line with 
a study in southern Ethiopia, wherein the HIV preva-
lence was 18% for females and 21% for males (Yassin 
et al. 2004), in Eastern India including 42 (10.3%) males 
and 8 (02%) females (Manjareeka and Nanda 2013), 
and in Pakistan (Hasnain et al. 2012). However, the 
present work was contradicted by studies in Nigeria 
in which the prevalence of co-infection was found to 
be higher among females (44.82%) than among males 
(38.30%) (Pennap et al. 2010), and in a study conducted 
in Ghana, wherein the percentage was 15.1% in males 
and 24.1% in females (Osei et al. 2017).
The current study also showed slightly higher fre-
quency in patients residing in an urban area (14.5%), 
while only 13.2% was noted in patients residing in 
a  rural area. This outcome was in line with a related 
study carried out in the southern region of Ethiopia 
(Yassin et al. 2004).
Statistical significance was detected when compar-
ing HIV co-infection in pulmonary TB and extrapul-
monary TB; the frequencies of pulmonary TB and 
extrapulmonary TB were 17% and 4.8%, respectively. 
Similar findings have been found in studies carried out 
in southern Ethiopia, which reported 19% of pulmo-
nary TB, and 11% of the patients with extrapulmonary 
TB were HIV positive (Yassin et al. 2004). Nevertheless, 
these findings were not in agreement with studies in 
India and Pakistan (Hasnain et  al. 2012; Manjareeka 
and Nanda 2013), because of a limited number of 
HIV cases detected in their reports. The seroprevalence 
of HIV infection among TB-infected patients was iden-
tified in this study in Kassala State, Eastern Sudan, 
and showed a high burden of HIV infection among 
active TB patients.
In strict compliance with the WHO, the CDC 
recommends that all patients with newly diagnosed TB 
be screened for HIV after consultation. TB reactivation 
can be minimized by TB preventive therapy and univer-
sal access to ART for people living with HIV.
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